home / stock / torc / torc news

TORC News and Press, resTORbio Inc. From 05/09/19

Stock Information
Company Name: resTORbio Inc.
Stock Symbol: TORC
Market: NASDAQ
Website: restorbio.com
Menu
TORC TORC Quote TORC Short TORC News TORC Articles TORC Message Board
Get TORC Alerts

News, Short Squeeze, Breakout and More Instantly...
TORC - resTORbio Announces Initiation of Phase 3 Clinical Program of RTB101 in Clinically Symptomatic Respiratory Illness

BOSTON, May 09, 2019 (GLOBE NEWSWIRE) -- resTORbio, Inc. (Nasdaq: TORC), today announced the initiation of PROTECTOR 1, the first Phase 3 trial of RTB101, an orally administered, small molecule, potent inhibitor of target of rapamycin complex 1 (TORC1). The two PROTECTOR Phase 3 trials are ...
TORC - resTORbio to Participate at Upcoming Investor Conferences in May

BOSTON, May 01, 2019 (GLOBE NEWSWIRE) -- resTORbio, Inc. (Nasdaq: TORC), a clinical-stage biopharmaceutical company developing innovative medicines that target the biology of aging to prevent or treat aging-related diseases, today announced that company management will participate in two in...

TORC - resTORbio Announces Initiation of Phase 1b/2a Trial of RTB101 in Parkinson's Disease

BOSTON, April 02, 2019 (GLOBE NEWSWIRE) -- resTORbio, Inc. (Nasdaq: TORC), a clinical-stage biopharmaceutical company developing innovative medicines that target the biology of aging to prevent or treat age-related diseases, today announced the initiation of a Phase 1b/2a trial of RTB101, i...

TORC - resTORbio announces closing public offering of common stock

resTORbio ( TORC +1.6% ) announced the closing of its previously announced underwritten public offering of 7.2M shares of its common stock at a public offering price of $6.95/share. More news on: resTORbio, Inc., Read more ...

TORC - resTORbio, Inc. Announces Closing Public Offering of Common Stock

BOSTON, March 22, 2019 (GLOBE NEWSWIRE) -- resTORbio, Inc. (“resTORbio” or the “Company”) (Nasdaq:TORC), a clinical-stage biopharmaceutical company developing innovative medicines that target the biology of aging to prevent or treat age-related diseases, today an...

TORC - AUPH, LXRX and TEUM among premarket gainers

Motif Bio plc (NASDAQ: MTFB ) +55%  on iclaprim meeting with FDA. More news on: Motif Bio plc, China Bat Group, Inc., Nevro Corp., Stocks on the move, Read more ...

TORC - ResTORbio +4% on pricing stock offering at $6.95

ResTORbio (NASDAQ: TORC ) prices a public offering of 7.2M common stock at a price of $6.95/share for gross proceeds of ~$50M. More news on: resTORbio, Inc., Healthcare stocks news, Stocks on the move, Read more ...

TORC - resTORbio, Inc. Announces Pricing of Public Offering of Common Stock

BOSTON, March 19, 2019 (GLOBE NEWSWIRE) -- resTORbio, Inc. (“resTORbio” or the “Company”) (Nasdaq:TORC), a clinical-stage biopharmaceutical company developing innovative medicines that target the biology of aging to prevent or treat age-related diseases, today an...

TORC - Healthcare dominate midday movers

Gainers:  Vaxart (NASDAQ: VXRT ) +108% . Sorrento Therapeutics (NASDAQ: SRNE ) +34% . Conformis (NASDAQ: CFMS ) +23% . Blucora (NASDAQ: BCOR ) +20% . StoneCo (NASDAQ: STNE ) +19% . Realm Therapeutics ( RLM ) +19% . Iterum Therapeutics (NASDAQ: ITRM ) +18% . Altimmune (NASDAQ: A...

TORC - resTORbio, Inc. Announces Proposed Public Offering of Common Stock

BOSTON, March 18, 2019 (GLOBE NEWSWIRE) -- resTORbio, Inc. ("resTORbio" or the "Company") (Nasdaq: TORC), a clinical-stage biopharmaceutical company developing innovative medicines that target the biology of aging to prevent or treat age-related diseases, today announced that it has commenc...
Previous 10 Next 10